Relmada Therapeutics Inc (RLMD) Insider Trading
- $1,439,435.83
- $9,744,532.36
- Sept. 11, 2024
- Sergio Traversa
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 11, 2024 | CEO | 51,407 | $2.99 | Buy | $153,706.93 | |
Sept. 11, 2024 | CFO | 24,120 | $2.95 | Buy | $71,154.00 | |
Sept. 9, 2024 | CEO | 55,579 | $2.71 | Buy | $150,619.09 | |
Sept. 9, 2024 | Director | 13,000 | $2.56 | Buy | $33,280.00 | |
Sept. 9, 2024 | CFO | 8,194 | $2.55 | Buy | $20,894.70 | |
Jan. 31, 2024 | CEO | 27,460 | $4.00 | Buy | $109,840.00 | |
Jan. 31, 2024 | CFO | 6,875 | $4.06 | Buy | $27,912.50 | |
Jan. 30, 2024 | Insider | 14,500 | $3.87 | Buy | $56,115.00 | |
Jan. 29, 2024 | CEO | 31,541 | $3.71 | Buy | $117,017.11 | |
Jan. 29, 2024 | CFO | 10,800 | $3.65 | Buy | $39,420.00 | |
May 23, 2023 | Insider | 10,000 | $3.18 | Buy | $31,800.00 | |
Dec. 8, 2022 | CEO | 55,250 | $2.10 | Buy | $116,025.00 | |
June 30, 2022 | CEO | 16,012 | $19.13 | Sell | $306,309.56 | |
April 4, 2022 | Director | 10,000 | $30.04 | Sell | $300,400.00 | |
Sept. 22, 2021 | Director | 6,600 | $29.00 | Sell | $191,400.00 | |
July 15, 2021 | Director | 3,300 | $31.54 | Sell | $104,082.00 | |
June 1, 2021 | Director | 3,000 | $33.34 | Sell | $100,020.00 | |
April 1, 2021 | Director | 3,000 | $35.43 | Sell | $106,290.00 | |
March 10, 2021 | CFO | 2,373 | $35.11 | Sell | $83,316.03 | |
March 9, 2021 | Director | 5,000 | $35.71 | Sell | $178,550.00 | |
March 9, 2021 | CEO | 7,017 | $35.65 | Sell | $250,156.05 | |
March 8, 2021 | CFO | 100 | $35.00 | Sell | $3,500.00 | |
Feb. 10, 2021 | CFO | 2,410 | $35.20 | Sell | $84,832.00 | |
Feb. 10, 2021 | CEO | 1,930 | $35.28 | Sell | $68,090.40 | |
Feb. 8, 2021 | CEO | 3,313 | $35.03 | Sell | $116,054.39 | |
Feb. 8, 2021 | CFO | 3,603 | $35.04 | Sell | $126,249.12 | |
Feb. 8, 2021 | Director | 1,500 | $35.04 | Sell | $52,560.00 | |
Feb. 3, 2021 | CEO | 3,278 | $35.07 | Sell | $114,959.46 | |
Feb. 3, 2021 | CFO | 3,200 | $35.04 | Sell | $112,128.00 | |
Feb. 1, 2021 | Director | 3,000 | $33.63 | Sell | $100,890.00 | |
Jan. 27, 2021 | Director | 5,000 | $32.46 | Sell | $162,300.00 | |
Jan. 27, 2021 | CFO | 3,000 | $31.93 | Sell | $95,790.00 | |
Jan. 26, 2021 | CEO | 600 | $35.15 | Sell | $21,090.00 | |
Jan. 25, 2021 | Director | 1,300 | $35.27 | Sell | $45,851.00 | |
Jan. 25, 2021 | CFO | 1,280 | $35.27 | Sell | $45,145.60 | |
Jan. 22, 2021 | Director | 2,100 | $3,042.03 | Sell | $6,388,263.00 | |
Jan. 22, 2021 | CFO | 2,113 | $35.55 | Sell | $75,117.15 | |
Jan. 22, 2021 | CEO | 2,170 | $35.58 | Sell | $77,208.60 | |
Nov. 2, 2020 | Director | 3,000 | $30.29 | Sell | $90,870.00 | |
Sept. 1, 2020 | Director | 3,000 | $34.74 | Sell | $104,220.00 | |
Aug. 3, 2020 | Director | 3,000 | $35.74 | Sell | $107,220.00 | |
July 1, 2020 | Director | 3,000 | $43.89 | Sell | $131,670.00 | |
Oct. 18, 2019 | Director | 5,000 | $30.00 | Buy | $150,000.00 | |
May 14, 2019 | Director | 100,000 | $1.50 | Buy | $150,000.00 | |
Dec. 11, 2018 | Director | 5,000 | $1.21 | Buy | $6,050.00 | |
Oct. 12, 2018 | Director | 150,000 | $0.90 | Buy | $135,000.00 | |
Dec. 16, 2015 | Director | 1,100 | $3.43 | Buy | $3,773.00 | |
Dec. 15, 2015 | Director | 3,000 | $2.99 | Buy | $8,970.00 | |
Dec. 15, 2015 | CEO | 18,970 | $3.05 | Buy | $57,858.50 |
Insiders are both buying and selling Relmada Therapeutics Inc stock.
The insider traders at Relmada Therapeutics Inc are: Maged Shenouda, Sergio Traversa, Paul Edward Kelly, Charles J Casamento, Shreeram Agharkar, Charles J. Casamento, Chuck Ence, and Cedric O'gorman
The most active insider trader at Relmada Therapeutics Inc is Maged Shenouda with 13 trades.
Paul Edward Kelly has sold the most Relmada Therapeutics Inc stock with a total value of $7,428,324.00.
Sergio Traversa has bought the most Relmada Therapeutics Inc stock with a total value of $858,773.56.
The most recent insider trade for Relmada Therapeutics Inc was on Sept. 11, 2024.
The single biggest insider buy for Relmada Therapeutics Inc was from Sergio Traversa with a total value of $153,706.93 on Sept. 11, 2024.
The single biggest insider sell for Relmada Therapeutics Inc was from Paul Edward Kelly with a total value of $6,388,263.00 on Jan. 22, 2021.